Mad in America

JANUARY 29, 2024

If one reads the ADM literature, it is quite apparent that the pharmaceutical industry—with the help of psychiatry—since day one has been involved in a cover up of the dangerousness of these drugs. of the drugs reviewed had two or fewer cases of violence, which is reassuring for most pharmaceuticals. meprobamate) as well.

Healthcare 98

Healthcare Pharmaceuticals Hospitality Aging and mental health 98

Mad in America

NOVEMBER 27, 2024

The mental health industry, including therapists, pharmaceutical companies, and even heads of departments and trauma experts, have a vested interest in diagnosing as many individuals as possible. By the mid-2020, the hashtag #TraumaDumping had garnered over 2 billion views on platforms like TikTok and Instagram.

Resilience and coping 132

Resilience and coping Nutrition and mood Self-awareness Sleep and mental health 132

Mad in America

DECEMBER 25, 2023

These drugs have often become the sole treatment for a variety of behavioral health disorders including clinical depression, anxiety disorders, obsessive compulsive disorder, and other approved and off-label uses of these drugs.

Neurotransmitters and mental health 77

Neurotransmitters and mental health Healthcare Self-awareness Aging and mental health 77

Mad in America

MARCH 15, 2025

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). accepting personal or office gifts or corporate donations from industry.

Neurotransmitters and mental health 103

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals 103